moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
[PR Newswire] – THE WOODLANDS, Texas, Feb. 28, 2014 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
[PR Newswire] – THE WOODLANDS, Texas, Feb. 20, 2014 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will release its fourth quarter and year end 2013 finan moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here […]
[at noodls] – The Woodlands, Texas, March 1, 2013 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur Sands, M.D., Ph.D., president and chief executive officer, will present at the Cowen Healthcare … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
[at noodls] – The Woodlands, Texas, February 25, 2013 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Brian Zambrowicz, Ph.D., executive vice president and chief scientific officer, will present … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
[at noodls] – Conference Call and Webcast at 11:00 a.m. Eastern Time The Woodlands, Texas, February 21, 2013 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
[at noodls] – LEXICON TO REPORT FOURTH QUARTER AND YEAR END 2012 FINANCIAL RESULTS ON FEBRUARY 21, 2013 Conference Call and Webcast to Follow The Woodlands, Texas, February 18, 2013 – Lexicon Pharmaceuticals, Inc. (Nasdaq: … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here […]
[at noodls] – The Woodlands, Texas, February 6, 2013 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur Sands, M.D., Ph.D., President and Chief Executive Officer, will present at the Bio CEO … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboardSee who Lexicon is hiring next, click here to view […]
[ACN Newswire] – On the surface, Galena Biopharma (NASDAQ:GALE) appears a late-stage oncology company focused on developing a promising breast cancer therapy. Beneath this mask, however, is a business rife with problems. … moreView todays social media effects on LXRXView the latest stocks trending across Twitter. Click to view dashboard […]
